Best of ASCO - 2014 Annual Meeting

 

Welcome

Immunobiology

Developmental Immunotherapy and Tumor Immunobiology

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
An effective and accurate algorithm for measuring the tumor mutation burden of cancer patients plasma.

Bo Liu

e14177

Anti-HER2/Neu antibody therapy can reduce the immunosuppressive activity of MDSCs in breast tumor model.

Il-Hwan Kim

e14181

Association of the imbalance between early and late differentiated intra-tumor CD4 T cells with mutational burden in non-small cell lung cancer.

Ehsan Ghorani

2590

Characterization of a patient-specific T-cell and tumor cell coculture model of immuno-cytotoxicity in colorectal cancer.

Yanhui Li

e14178

Characterizing the gut microbiome of patients with triple-negative breast cancer.

April T. Swoboda

e14186

Comprehensive analysis of lymphocyte loss kinetics in patients treated with focal fractionated radiation therapy.

Anirudh Yalamanchali

e14191

Correlation of CD28 expression on CD8+ T cells with prognosis in advanced lung adenocarcinomas and squamous cell carcinomas.

Chao Liu

e14185

Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer.

Jiajie Shi

e14187

Electron microscopic characteristic of local immune processes during regression of developed experimental tumors under the influence of magnetite nanoparticles.

Galina V. Zhukova

e14179

Evidence for selective silencing of MHC-binding neoepitopes to avoid immune surveillance.

Rahul Parulkar

2591

Immunobiology, preliminary safety, and efficacy of CPI-006, an anti-CD73 antibody with immune modulating activity, in a phase 1 trial in advanced cancers.

Jason J. Luke

2505

Precision probiotic therapy enhances immune checkpoint therapy efficacy in melanoma bearing mice.

Arthur E. Frankel

e14195

Quantitative assessment of immune cell populations and associations with clinical outcomes in African-American (AA) versus Caucasian triple-negative breast cancer (TNBC).

Tess O'Meara

e14180

STING-dependent preventive effect by ablative hyperfractioned radiotherapy and delayed delivery of a CSF-1R inhibitor.

Xiaowen Sun

e14190

The influences of preoperative metformin on immunological factors in early breast cancer.

Takahiro Takahiro

e14182

Tumor mutation burden analysis in a 5,660 cancer patient cohort reveals cancer type-specific mechanisms for high mutation burden.

Xiaodong Jiao

2589

Use of PD-L1 and ICOSL to discriminate innate and adaptive dendritic cells in the head and neck cancer microenvironment.

Caroline Hoffmann

e14184